Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy

Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy

Abstract Background NOD-like receptor protein 3 (NLRP3) inflammasome activation is indispensable for atherogenesis. Mitophagy has emerged as a potential strategy to counteract NLRP3 inflammasome activation triggered by impaired mitochondria. Our previous research has indicated that dihydromyricetin,...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Qin Hu, Chengying Li, Ting Zhang, Long Yi, Yifan Shan, Xiangyu Ma, Tongjian Cai, Li Ran, Hui Shen, Yafei Li
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: BMC 2024-09-01
Sarja:Lipids in Health and Disease
Aiheet:
Atherosclerosis
Dihydromyricetin
Mitophagy
NLRP3 inflammasome
Vascular endothelium
Linkit:https://doi.org/10.1186/s12944-024-02263-1

Internet

https://doi.org/10.1186/s12944-024-02263-1

Samankaltaisia teoksia